Balancing “make, buy and ally” in life sciences
Download the article to read all the content on which this summary is based.
Balancing make, buy and ally is one of the key drivers of corporate value for life sciences companies. In many cases, business alliances prevail as a way to boost innovation and growth in addition to in-house innovation efforts (make) and active merger and acquisitions efforts (buy).
The biggest fear when entering an alliance is giving away too much information and receiving too little in return.
Despite significant value add, many business alliances fail to deliver the expected value.
Read the full article to find out how companies could manage their business alliance portfolios to help them reach their full potential.
The article was written by:
Read the full article 602.28 kB